ok that worked well...what I meant to say was...
the wording on page 15 'major pharma partners' appears to be quite specific;
Roche - collaboration - no mention of future cashflows
Medimmune - deal - 'can receive...'
Pfizer - license - 'can receive...'
Janssen - collaboration - no mention of future cashflows
Genentech - 'licensing deal' - 'can receive...'
I suspect the author has looked at each document and determined which are still live, albeit in hibernation. Perhaps reading too much into it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |